Cargando…
Sustained Release of an Anti-Glaucoma Drug: Demonstration of Efficacy of a Liposomal Formulation in the Rabbit Eye
Topical medication remains the first line treatment of glaucoma; however, sustained ocular drug delivery via topical administration is difficult to achieve. Most drugs have poor penetration due to the multiple physiological barriers of the eye and are rapidly cleared if applied topically. Currently,...
Autores principales: | Natarajan, Jayaganesh V., Chattopadhyay, Sujay, Ang, Marcus, Darwitan, Anastasia, Foo, Selin, Zhen, Ma, Koo, Magdalene, Wong, Tina T., Venkatraman, Subbu S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170360/ https://www.ncbi.nlm.nih.gov/pubmed/21931735 http://dx.doi.org/10.1371/journal.pone.0024513 |
Ejemplares similares
-
Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye
por: Natarajan, Jayaganesh V, et al.
Publicado: (2012) -
Biocompatibility and Biodegradation Studies of Subconjunctival Implants in Rabbit Eyes
por: Peng, Yan, et al.
Publicado: (2011) -
Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab
por: Joseph, Rini Rachel, et al.
Publicado: (2017) -
Evaluation of a Prednisolone Acetate-Loaded Subconjunctival Implant for the Treatment of Recurrent Uveitis in a Rabbit Model
por: Ang, Marcus, et al.
Publicado: (2014) -
Hybrid Formulations of Liposomes and Bioadhesive Polymers Improve the Hypotensive Effect of the Melatonin Analogue 5-MCA-NAT in Rabbit Eyes
por: Quinteros, Daniela, et al.
Publicado: (2014)